Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

ClinicalTrials.gov ID: NCT06237049

Public ClinicalTrials.gov record NCT06237049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies to defend the body against both SARS-CoV-2 (the virus that causes COVID-19) and influenza. Participants enrolled in this trial will be healthy adults, 50 years of age or older.

Study identification

NCT ID
NCT06237049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
644 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2024 (Actual)
Primary completion
Sep 13, 2024 (Actual)
Completion
Sep 13, 2024 (Actual)
Last update posted
Sep 30, 2025

2024

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Orange County Research Center Lake Forest California 92630 —
Orange County Research Center Tustin California 92780 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Clinical Research Consulting Milford Connecticut 06460 —
GW Medical Faculty Associates Washington D.C. District of Columbia 20037 —
GW Vaccine Research Unit Washington D.C. District of Columbia 20037 —
JEM Research Institute Atlantis Florida 33462 —
Indago Research & Health Center, Inc Hialeah Florida 33012 —
Optimal Research Melbourne Florida 32934 —
Headlands Research Orlando Orlando Florida 32819 —
Clinical Site Partners, LLC dba Flourish Research Winter Park Florida 32789 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Optimal Research Peoria Illinois 61614 —
Bio-Kinetic Clinical Applications, LLC dba QPS-MO Springfield Missouri 65802 —
Bio-Kinetic Clinical Applications, LLD dba QPS-MO Springfield Missouri 65802 —
Bio-Kinetic Clinical Applications LLC DBA QPS-MO(Patient Screening Center) Springfield Missouri 65807 —
Las Vegas Clinical Trials Las Vegas Nevada 89030 —
Las Vegas Clinical Trials North Las Vegas Nevada 89030 —
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801 —
Rochester Clinical Research, LLC Rochester New York 14609 —
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213 —
Clinical Research Associates Inc Nashville Tennessee 37203 —
DM Clinical Research- Cyfair Houston Texas 77065 —
DM Clinical Research - Bellaire Houston Texas 77081 —
SMS Clinical Research Mesquite Texas 75149 —
Clinical Trials of Texas, LLC San Antonio Texas 78229 —
IMA Clinical Research San Antonio San Antonio Texas 78229 —
DM Clinical Research - MDC Tomball Texas 77375 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06237049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2025 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06237049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →